1. Academic Validation
  2. Onradivir: a novel influenza polymerase inhibitor

Onradivir: a novel influenza polymerase inhibitor

  • Lancet Respir Med. 2025 Jul;13(7):571-573. doi: 10.1016/S2213-2600(25)00128-6.
Jingya Li 1 Yeming Wang 2 Bin Cao 3
Affiliations

Affiliations

  • 1 School of Medicine, Tsinghua Medicine, Tsinghua University, Beijing, China.
  • 2 Capital Medical University, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China.
  • 3 Capital Medical University, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China; Tsinghua University-Peking University Joint Center for Life Sciences, Beijing, China. Electronic address: [email protected].
Figures
Products